In this case example, learn the latest data about whether to use tenofovir alafenamide during pregnancy.
Learn the latest data about whether to use tenofovir alafenamide during pregnancy.
Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares key data and recommendations to support the use of TAF in pregnancy.
In this on-demand recording of a live webinar, expert faculty review key considerations for the use of ART in pregnancy. Topics include current recommendations and a discussion of the data to support ART options during pregnancy.
Learn key considerations for the use of ART in older PWH. Topics include current data and recommendations on polypharmacy, drug-drug interactions, drug-disease state interactions, and cardiovascular risk considerations
In this on-demand recording of a live webinar, expert faculty review key considerations for the use of ART in older PWH. Topics include current data and recommendations on polypharmacy, drug–drug interactions, drug–disease state interactions, and cardiovascular risk considerations.
In this case example, learn the latest data about maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.
Learn the latest data about maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.
Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares the latest data on maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.
Many patients are receiving BIC/FTC/TAF as an initial ART regimen, but what should you do if these patients become pregnant?
Learn key considerations for the use of ART in pregnancy. Topics include current recommendations and a discussion of the data to support ART options during pregnancy.
In this case example, learn some of the key considerations for ART management for transgender PWH including providing care within a gender-affirmative care model, considering drug-drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.
Learn some of the key considerations for ART management for transgender PWH including providing care within a gender-affirmative care model, considering drug-drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.
Listen as Dr Michelle D. Collins-Ogle shares some of the key considerations for ART management for transgender PWH, including providing care within a gender-affirmative care model, considering drug–drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.
Download this PDF to share with your patients with HIV who are pregnant or considering pregnancy.
In this on-demand recording of a live webinar, expert faculty review key renal and hepatic considerations, such as how to choose ART and what to monitor in older PWH.
In this case example, learn some of the key considerations for choosing ART for pediatric patients, including HIV exposed newborns, and children and adolescents infected with HIV.
Learn some of the key considerations for choosing ART for pediatric patients including for HIV exposed newborns, and children and adolescents infected with HIV.
Listen as Dr Michelle D. Collins-Ogle shares some of the key considerations for choosing ART for pediatric patients, including for HIV-exposed newborns and children and adolescents infected with HIV.
Learn key considerations for the use of ART in older PWH. Topics include current data and recommendations on renal impairment and liver disease.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.